核受容体Rev-erbalphaは,日中時計のリチウムに敏感な重要な構成要素である
Lei Yin1, Jing Wang, Peter S Klein
1Division of Endocrinology, Diabetes, and Metabolism, and University of Pennsylvania School of Medicine, 415 Curie Boulevard, Philadelphia, PA 19104, USA.
まとめ
リチウム治療は,日中時計タンパク質のRev-erbalphaを劣化させ,Bmal1遺伝子を活性化させます. この発見は,リチウムの重要なメカニズムを明らかにしています.
科学分野:
- クロノバイオロジー クロノバイオロジー
- 分子薬理学 分子薬理学
- 神経精神病学は神経精神病学である.
背景:
- 双極性障害は,昼夜リズムが乱れていることと関連しています.
- リチウムは,一般的な双極性障害の治療法であり,グリコゲン合成キナーゼ3 (GSK3) を阻害する.
- GSK3は,様々な生物の昼夜リズムを調節する.
研究 の 目的:
- リチウム,GSK3,および昼夜リズム調節を結びつける分子メカニズムを調査する.
- 昼間の時計のコンポーネントの安定化におけるGSK3βの役割を決定するためにRev-erbalpha.
- リチウムのRev-erbalphaの安定性への影響と,時計遺伝子発現への影響について調べる.
主な方法:
- 培養細胞を用いて,タンパク質とタンパク質の相互作用と分解経路を調べました.
- GSK3βがRev-erbalpha.に与えるリン酸化と安定化の効果を研究した.
- リチウム治療がRev-erbalphaレベルとBmal1遺伝子発現に与える影響を評価した.
- リチウム無感のRev-erbalpha変異体を使って実験し,その機能を理解した.
主要な成果:
- GSK3βは,日中時計タンパク質Rev-erbalphaをリン酸化し,安定させることが判明しました.
- リチウム治療は,培養細胞におけるRev-erbalphaの急速なプロテアソマル分解を誘発した.
- Rev-erbalphaの分解は,日中時計遺伝子Bmal1.1の活性化につながった.
- リチウム無感のRev-erbalpha変異体は,日中活動中の遺伝子発現を妨害し,その調節作用を確認した.
結論:
- Rev-erbalphaタンパク質の安定性は,周辺の昼間の時計の重要な調節因子である.
- リチウム療法のメカニズムは,Rev-erbalpha.の標的化された分解を伴う.
- この研究では,リチウムのサーカディアンリズム調節における治療効果の重要な生物学的標的としてRev-erbalphaを特定しています.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Circadian Rhythms and Gene Regulation
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Circadian Rhythms and Gene Regulation
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:


